|
Symbol
|
Z09YJZ | Z0ALWZ | Z0ASJZ | Z0ATQZ | SKS6LK | RMBD1V | RMBXZV | ROMRCH |
|---|---|---|---|---|---|---|---|---|
| Nom | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | LUKB Softcallable Multi Reverse Convertible | Multi Vonti | Multi Vonti | Worst of Callable Reverse Convertible |
|
Sous-jacent
|
Galderma Group AG / Sandoz Group AG / VAT Group | Alcon / Galderma Group AG / Siegfried Hldg. AG | Galderma Group AG / Sika AG / Swiss Life Hldg. N | Galderma Group AG / Sandoz Group AG / SIG Combibloc / VAT Group | Galderma Group AG / Novartis AG / Sika AG | Galderma Group AG / L'Oréal S.A. / Ulta Beauty | Galderma Group AG / Lonza Group N / Roche AG / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
Échéance
|
02.02.2026 | 27.07.2026 | 27.08.2026 | 07.09.2026 | 07.04.2027 | 13.02.2026 | 20.12.2027 | 23.07.2027 |
| Ratio | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
337,029 | 66,7876 | 186,282 | 12,496 | 174,48 | 299,664 | 106,30 | 119,325 |
| rendement max. p.a. | - | 27,36% | 49,57% | 23,99% | 22,18% | 1,34% | 6,21% | 8,16% |
| Demande | - | - | - | - | - | - | 97,10 | 96,56 |
| Offre | - | - | - | - | - | - | 97,90 | 97,36 |